CompanyClimateHealth
Meiogenix
Meiogenix is a French-American agricultural biotech company that re-engineers one of nature's oldest tricks - meiotic recombination, the gene-shuffling that happens when plants make seeds. Instead of editing single genes like CRISPR, its proprietary SpiX and dCas9-SPO11 platforms steer where chromosomes cross over, unlocking 'cold' regions of the genome that conventional breeding can never reach. The result: breeders can mix desirable traits, break unwanted linkage, and shrink crop development cycles from 10-plus years to as few as three, all without introducing foreign DNA. Founded in 2010 as a spin-off from Institut Curie and INRA, the company targets the $50B+ commercial seed market across corn, wheat, rice, tomato and soybean, and licenses its technology to partners including Bayer.
2010Founded
ParisHQ
$13M (≈€11M)Series A
biotechagricultureplant breedingcrop geneticsmeiotic recombinationgenome engineering
